AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
BackgroundVascular endothelial growth factors (VEGFs) are major regulators of intratumoral angiogenesis in ovarian cancer (OVCA). Overexpression of VEGFs is associated with increased tumor growth and metastatic tendency and VEGF-targeting therapies are thus considered as potential treatments for OVC...
Main Authors: | Anni Kujala, Elina Valkonen, Hanna Sallinen, Laura Tuppurainen, Hanne Laakso, Elias Ylä-Herttuala, Timo Liimatainen, Jouni Kujala, Otto Jokelainen, Reijo Sironen, Maarit Anttila, Seppo Ylä-Herttuala |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1018208/full |
Similar Items
-
Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance TRAFFn, T1ρ and T2 relaxation times
by: Elias Ylä-Herttuala, et al.
Published: (2023-01-01) -
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
by: Minna Sopo, et al.
Published: (2019-06-01) -
Quantification of myocardial infarct area based on TRAFFn relaxation time maps - comparison with cardiovascular magnetic resonance late gadolinium enhancement, T1ρ and T2 in vivo
by: Elias Yla-Herttuala, et al.
Published: (2018-06-01) -
VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms
by: Grażyna Gadomska, et al.
Published: (2017-01-01) -
AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery
by: Sanna Koponen, et al.
Published: (2023-07-01)